John Gregson
Impact in
-
- Antiplatelet Therapy and Cardiovascular Diseases
- Heart Failure Treatment and Management
- Cardiomyopathy and Myosin Studies
- Internal Medicine top 2%
Papers in
-
- Heart Failure Treatment and Management 10
- Cardiomyopathy and Myosin Studies 9
- Acute Myocardial Infarction Research 7
- Antiplatelet Therapy and Cardiovascular Diseases 6
-
- Statistical Methods in Clinical Trials 14
- Co-authors
- Stuart Pocock (42 shared papers)Gregg W. Stone (10 shared papers)Roxana Mehran (4 shared papers)Usman Baber (4 shared papers)Samantha Sartori (3 shared papers)Nawab Qizilbash (4 shared papers)Ian Douglas (3 shared papers)Neil Pearce (3 shared papers)
- Journals
- Journal of the American College of Cardiology (17 papers)European Journal of Heart Failure (12 papers)European Heart Journal (10 papers)Stroke (9 papers)Circulation (7 papers)
- Partner nations
- United KingdomUnited StatesFrance
In The Last Decade
John Gregson
126 papers receiving 9.6k citations
John Gregson's Hit Papers
Peers
Comparison fields: 5 of 126
- Cardiology and Cardiovascular Medicine 2.8k
- Internal Medicine 166
- Infectious Diseases 827
- Surgery 1.2k
- Rehabilitation 148
Countries citing papers authored by John Gregson
This map shows the geographic impact of John Gregson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Gregson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Gregson more than expected).
Fields of papers citing papers by John Gregson
This network shows the impact of papers produced by John Gregson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Gregson. The network helps show where John Gregson may publish in the future.
Co-authors
The 25 scholars most cited alongside John Gregson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 130 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Polymer-free Drug-Coated Coronary Stents in Patients at High Bleeding Risk Hit paper breakdown → | 2015 | 651 |
| 2 | Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention Hit paper breakdown → | 2019 | 623 |
| 3 | Comparison of Propensity Score Methods and Covariate Adjustment Hit paper breakdown → | 2017 | 567 |
| 4 | Five-Year Outcomes after PCI or CABG for Left Main Coronary Disease Hit paper breakdown → | 2019 | 526 |
| 5 | Environmental toxic metal contaminants and risk of cardiovascular disease: systematic review and meta-analysis Hit paper breakdown → | 2018 | 488 |
| 6 | Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trial Hit paper breakdown → | 2018 | 466 |
| 7 | Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding Risk Hit paper breakdown → | 2019 | 447 |
| 8 | BMI and risk of dementia in two million people over two decades: a retrospective cohort study Hit paper breakdown → | 2015 | 386 |
| 9 | Prevalence, Impact, and Predictive Value of Detecting Subclinical Coronary and Carotid Atherosclerosis in Asymptomatic Adults Hit paper breakdown → | 2015 | 382 |
| 10 | HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysis Hit paper breakdown → | 2017 | 327 |
| 11 | 2012 | 306 | |
| 12 | 2017 | 297 | |
| 13 | Cardiovascular Risk Factors Associated With Venous Thromboembolism Hit paper breakdown → | 2019 | 264 |
| 14 | 2018 | 263 | |
| 15 | 2000 | 255 | |
| 16 | 2016 | 222 | |
| 17 | 2019 | 220 | |
| 18 | Survival Outcomes and Prognostic Factors in Glioblastoma Hit paper breakdown → | 2022 | 162 |
| 19 | 2020 | 153 | |
| 20 | 2018 | 132 |
About John Gregson
John Gregson is a scholar working on Cardiology and Cardiovascular Medicine, Statistics and Probability, Pulmonary and Respiratory Medicine, Infectious Diseases and Psychiatry and Mental health, having authored 130 papers that have together received 10.0k indexed citations. Recurring topics across this work include Cerebrovascular and Carotid Artery Diseases (17 papers), Statistical Methods in Clinical Trials (14 papers), Heart Failure Treatment and Management (10 papers), Cardiomyopathy and Myosin Studies (9 papers), Acute Myocardial Infarction Research (7 papers), HIV/AIDS drug development and treatment (6 papers), Antiplatelet Therapy and Cardiovascular Diseases (6 papers) and Dementia and Cognitive Impairment Research (5 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (2.8k citations), Internal Medicine (166 citations), Infectious Diseases (827 citations), Surgery (1.2k citations) and Rehabilitation (148 citations). John Gregson has collaborated with scholars based in United Kingdom, United States and France. Frequent co-authors include Stuart Pocock, Gregg W. Stone, Roxana Mehran, Usman Baber, Samantha Sartori, Nawab Qizilbash, Ian Douglas, Neil Pearce, Stephen Evans and Markus C. Elze. Their work appears in journals such as Journal of the American College of Cardiology, European Journal of Heart Failure, European Heart Journal, Stroke and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.